Eupraxia Pharmaceuticals (TSX:EPRX) FFO


TSX:EPRX Eupraxia Pharmaceuticals Inc TSX:EPRX
37 GF Score
Price C$9.38
! 1 Warning Sign
View Full Analysis

What is Eupraxia Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

TSX:EPRX
37GF Score
Eupraxia Pharmaceuticals Inc TSX:EPRX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eupraxia Pharmaceuticals Business Description

Other Exchanges EPRX:USAX43:Germany
Address 201 2067 Cadboro Bay Road, Victoria, BC, CAN, V8R 5G4
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.
37GF Score

Get the complete analysis for TSX:EPRX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$9.38
Price